↓ Skip to main content

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
210 Dimensions

Readers on

mendeley
205 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
Published in
Journal of Experimental & Clinical Cancer Research, February 2019
DOI 10.1186/s13046-019-1085-3
Pubmed ID
Authors

Xin Wang, Gaochao Guo, Hui Guan, Yang Yu, Jie Lu, Jinming Yu

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 205 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 205 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 13%
Student > Bachelor 24 12%
Student > Ph. D. Student 21 10%
Researcher 19 9%
Student > Postgraduate 12 6%
Other 27 13%
Unknown 75 37%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 40 20%
Medicine and Dentistry 33 16%
Agricultural and Biological Sciences 13 6%
Neuroscience 13 6%
Immunology and Microbiology 11 5%
Other 17 8%
Unknown 78 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 October 2021.
All research outputs
#3,276,501
of 25,385,509 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#165
of 2,382 outputs
Outputs of similar age
#70,417
of 366,368 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#9
of 87 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,382 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,368 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.